Engineering the medicines of tomorrow

Engineering the medicines of tomorrow

We are dedicated to bringing breakthrough medicines in oncology to the market to help address the unmet needs of patients with life-threatening diseases.

With our skills and knowledge, we have built a comprehensive portfolio of potential drug candidates.

Drawing of bubbling beakers

The Therapeutic Pipeline

MorphoSys has one of the broadest pipelines in biotech:

  • 100 distinct drugs currently in research and development
  • 24 therapeutic antibodies in clinical trials as potential novel treatment options for severe and life-threatening diseases
  • For information on the complete MorphoSys clinical pipeline, visit morphosys.com/pipeline

Oncology Pipeline

Development Discovery
Phase 1
Clinical Trial Phase 1
Phase 2
Clinical Trial Phase 2
Phase 3
Clinical Trial Phase 3
In Market